ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's WhyBenzinga • 11/08/24
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/07/24
ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational UpdatePRNewsWire • 11/07/24
ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual MeetingPRNewsWire • 11/05/24
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 11/01/24
ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024PRNewsWire • 10/31/24
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/06/24
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational UpdateGlobeNewsWire • 08/06/24
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024GlobeNewsWire • 07/30/24
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentGlobeNewsWire • 07/08/24
ADC Therapeutics to Participate in the Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/30/24
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQGlobeNewsWire • 05/15/24
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/09/24
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/06/24
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded WarrantsGlobeNewsWire • 05/06/24
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesGlobeNewsWire • 05/06/24